In addition, the patients with higher expression of p62 had shorter overall survival than those with lower expression of p62, indicating that the p62 level was an independent risk factor for a poor prognosis in CRC patients (Figure 1F, P = 0.01 and Table 2, P < 0.05). The gene discussed is SQSTM1; the disease is colorectal carcinoma.